Glucose Patents (Class 436/95)
  • Patent number: 8293539
    Abstract: An analysis system for detecting at least one analyte in a sample is proposed, in particular for detecting glucose in a bodily fluid. The analysis system is designed to detect the analyte using at least one test element. The test element has at least one analysis zone for detecting the analyte. The test element includes at least one coding with at least one test element specific item of information and/or at least one position specific item of information. The analysis system includes a detector and furthermore at least one transfer device which is designed to afford the detector the possibility of acquiring the analysis zone in at least a first position and to afford the detector the possibility of acquiring the coding in at least a second position which differs from the first position.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: October 23, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Wolfgang Petrich, Stefan Kalveram, Markus Serr
  • Patent number: 8285487
    Abstract: Methods, devices and a system for disease management are provided that employ diagnostic testing devices (e.g., blood glucose meters) and medication delivery devices (e.g., insulin delivery devices) for providing data to a repository in real-time and automatically. Repository data can be analyzed to determine such information as actual test strip use, patient health parameters to outside prescribed ranges, testing and medication delivery compliance, patient profiles or stakeholders to receive promotional items or incentives, and so on. Connected meters and medication delivery devices and repository data analysis are also employed to associate a diagnostic test to a mealtime based on timing of a therapeutic intervention performed by an individual.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: October 9, 2012
    Assignee: Becton, Dickinson and Company
    Inventors: Chris Bergstrom, Jay Butterbrodt, Alan W. Fiedler, Barry Ginsberg, Tim H. Gordon, Paul Upham
  • Patent number: 8283175
    Abstract: A test device for determining the concentration of at least one analyte in a sample using a element is proposed. The test device can be used particularly for glucose measurement, in particular blood glucose measurement, cholesterol measurement and/or coagulation measurement. The test device according to the invention comprises a housing with a closed state and an opened state, and a storage device for receiving at least one test element. The at least one test element is typically designed as a strip-shaped test element, and the storage device typically comprises a magazine. The magazine comprises a plurality of cavities, and the test elements are received substantially parallel to one another in the cavities. A measuring device and a dispensing device are also provided. The dispensing device comprises means for conveying the at least one test element from at least one storage position of the storage device during opening of the housing.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: October 9, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Gregor Bainczyk, Thomas Eisele, Herbert Wieder
  • Publication number: 20120244624
    Abstract: An exemplary test strip reading and analyzing system includes a test strip unit, a mobile device and a remote computing apparatus. The test strip unit includes at least one tested-object reacting region. The mobile device includes an image capture module for capturing a test-strip image of the test strip unit and a transmission module electrically coupled to the image capture module. The remote computing apparatus, installed with a test strip analyzing system, is for analyzing the test-strip image and accordingly generating an test report. The test-strip image captured by the image capture module is transmitted to the remote computing apparatus through the transmission module; and the test report generated by the remote computing apparatus is consequently transmitted to the mobile device.
    Type: Application
    Filed: June 14, 2011
    Publication date: September 27, 2012
    Applicants: Middleland Sensing Technology Inc.
    Inventor: Hsiung Hsiao
  • Patent number: 8247233
    Abstract: An integrated meter system for determining information related to an analyte of a fluid sample includes a meter including a housing and a plurality of test sensors. Each of the plurality of test sensors includes a penetrating member, a testing portion, and a channel. The channel is adapted to receive the fluid sample. The test sensors are removably located within the housing. At least one of the test sensors is removably connected to an adjacent test sensor. The integrated meter system also includes a test-sensor advancement mechanism that is configured to advance the test sensors.
    Type: Grant
    Filed: December 9, 2008
    Date of Patent: August 21, 2012
    Assignee: Bayer Healthcare LLC
    Inventors: Igor Gofman, Mitchel Stein
  • Publication number: 20120201755
    Abstract: A method of detecting an analyte in a fluid includes the step of positioning a sensor probe in the fluid. The sensor probe includes a sensing element which absorbs in the infrared region of the spectrum in response to the analyte. The change is then detected with a detection system.
    Type: Application
    Filed: May 20, 2011
    Publication date: August 9, 2012
    Inventors: George Rozakis, Miklos Gratzl, Koji Tohda, Jian Yang
  • Patent number: 8233956
    Abstract: A medical device includes a connector which contacts a sensor to electrically connect the sensor with a measurement circuit in a medical device, a contact terminal which constitutes the connector, and a slide pin which ejects the sensor out of the medical device. The slide pin performs the operation of pushing up the contact terminal contacting the sensor as well as the operation of pushing the sensor out of the medical device. Since the contact terminal is completely lifted up by the inclined surface of the upper end part of the slide pin before the sensor is discarded, there occurs no reaction due to rebound of the contact terminal which might occur at the moment when the contact terminal of the connector is separated from the sensor, and thereby the sensor can be discarded so as to fall freely.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: July 31, 2012
    Assignee: Panasonic Corporation
    Inventors: Shinji Ohama, Eiichiro Izumi
  • Patent number: 8216847
    Abstract: The present invention relates to a method for diagnosing a predisposition for diabetes, comprising determining a metabolite in a test sample of a subject suspected to have a predisposition for diabetes and comparing the metabolite to a reference to diagnose the, predisposition for diabetes. Moreover, the present invention encompasses a collection of metabolites, a data collection comprising characteristic values of metabolites and a storage medium comprising the data collection. The present invention also relates to a system comprising methods or devices for comparing characteristic values of metabolites of a sample operatively linked to a data storage medium. Additionally, diagnostic methods or devices comprising a metabolite and its use for manufacture of the diagnostic method or device for diagnosing a predisposition for diabetes are provided, along with a method for identifying diabetes-related metabolites.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: July 10, 2012
    Assignee: Metanomics GmbH
    Inventors: Bianca Bethan, Kristina Busch, Jan C Wiemer, Martijn Gipmans, Edgar Leibold, Jochen Spranger, Thomas Bobbert, Andreas Friedrich Hermann Pfeiffer
  • Patent number: 8216848
    Abstract: The present invention relates to a method for diagnosing diabetes or a predisposition thereof, comprising determining at least one metabolite in a test sample of a subject suspected to suffer from diabetes or to have a predisposition therefor and comparing the metabolite to a reference to diagnose diabetes or a predisposition therefor. The present invention further encompasses a collection of metabolites, a data collection comprising characteristic values of metabolites and a storage medium comprising the data collection. The present invention also relates to a system comprising methods or devices for comparing characteristic values of metabolites of a sample operatively linked to a data storage medium. The present invention also encompasses diagnostic methods or devices comprising at least one metabolite and use of the metabolite for the manufacture of diagnostic methods and devices for diagnosing diabetes; and a method for identifying diabetes-related metabolites.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: July 10, 2012
    Assignee: Metanomics GmbH
    Inventors: Bianca Bethan, Kristina Busch, Jan C Wiemer, Martijn Gipmans, Edgar Leibold, Jochen Spranger, Thomas Bobbert, Andreas Friedrich Hermann Pfeiffer
  • Publication number: 20120171713
    Abstract: A semiconductor die includes a chemical sensor, a digital to analog converter, and microcontroller formed therein. The chemical sensor detects the presence of a chemical and outputs an analog signal to the digital to analog converter. The analog to digital converter converts the analog signal to a digital signal. The analog to digital converter outputs the digital signal to the microcontroller. Microcontroller calculates a value of the concentration of the selected chemical.
    Type: Application
    Filed: October 31, 2011
    Publication date: July 5, 2012
    Applicant: STMICROELECTRONICS PTE LTD.
    Inventors: Suman Cherian, Olivier Le Neel
  • Publication number: 20120171774
    Abstract: A chemical sensor is provided on a first semiconductor die. A potentiostat is provided on a second semiconductor die. An analog to digital converter and a microcontroller are provided on a third semiconductor die. The first die is configured to be connected to the second die. The second die is configured to be connected to the third die. The chemical sensor detects a chemical in the surrounding environment and outputs a signal to the analog to digital converter. The analog to digital converter converts the signal to a digital signal and outputs the digital signal to the microcontroller. The microcontroller provides a measurement of the concentration of the chemical in the surrounding environment.
    Type: Application
    Filed: October 31, 2011
    Publication date: July 5, 2012
    Applicant: STMICROELECTRONICS PTE LTD.
    Inventors: Suman Cherian, Olivier Le Neel
  • Publication number: 20120164671
    Abstract: Systems and methods are provided for monitoring a immunosuppressant drug level and renal function, hepatic function, or a combination thereof in a patient, comprising obtaining a small volume blood sample from the patient; determining the level of at least one immunosuppressant drug in the small volume blood sample and determining the level of a second immunosuppressant drug or analyzing the renal function, the hepatic function, or a combination thereof in the patient. In some embodiments, the immunosuppressant drug levels are determined using a liquid chromatography tandem mass spectrometry (LC-MS/MS) procedure. Also provided are kits for use in any of the systems and methods described herein.
    Type: Application
    Filed: February 29, 2012
    Publication date: June 28, 2012
    Inventor: Pleasant Fite Hooper
  • Publication number: 20120156793
    Abstract: The invention provides fluorophores of formulae (I) and (II) and also fluorescent sensor compounds comprising fluorophore moieties based on such fluorophores in combination with a receptor moiety. There is further provided a method of sensing the presence of a target analyte using the fluorescent sensor compound, as well as the use of the fluorescent sensor compounds to sense a target analyte.
    Type: Application
    Filed: April 8, 2010
    Publication date: June 21, 2012
    Inventor: Timothy Charles Higgs
  • Patent number: 8202731
    Abstract: Novel fluorescent dyes are disclosed for use in analyte detection. In particular, mono- and bis-substituted HPTS dyes and methods of making them are provided.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: June 19, 2012
    Assignee: Glumetrics, Inc.
    Inventor: Jeff T. Suri
  • Publication number: 20120149048
    Abstract: Glucose measured in blood samples is distinguished from glucose measured in the control solutions used to test the optical instruments which make such measurements. The control solutions contain a labeling substance recognized by the optical instrument to distinguish glucose measurements made of control solutions from those made of blood samples.
    Type: Application
    Filed: December 21, 2011
    Publication date: June 14, 2012
    Applicant: Bayer HealthCare, LLC
    Inventor: Karen L. Marfurt
  • Publication number: 20120122227
    Abstract: A guided structured testing kit comprising a test strip container, a test strip meter, a testing protocol advisor, and at least one of diagnostic test strip is presented. The diagnostic test strip comprising a support element, a glucose reagent provided on the support element, and a glycemic context code provided on the support element. The glycemic context code can be machine-readable. The glycemic context code signals a glycemic context to a test strip meter, either upon insertion of the diagnostic test strip or by a user manually inputting the glycemic context into the test strip meter. A method for performing a guided structured test is also provided.
    Type: Application
    Filed: November 15, 2010
    Publication date: May 17, 2012
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Christopher Wiegel, Colleen Csavas, Ulrich Porsch
  • Patent number: 8173436
    Abstract: Systems and methods for detecting the presence of biomolecules in a sample using biosensors that incorporate resonators which have functionalized surfaces for reacting with target biomolecules. In one embodiment, a device includes a piezoelectric resonator having a functionalized surface configured to react with target molecules, thereby changing the mass and/or charge of the resonator which consequently changes the frequency response of the resonator. The resonator's frequency response after exposure to a sample is compared to a reference, such as the frequency response before exposure to the sample, a stored baseline frequency response or a control resonator's frequency response.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: May 8, 2012
    Assignee: Intel Corporation
    Inventors: Yuegang Zhang, Andrew Berlin, Qing Ma, Li-Peng Wang, Valluri Rao, Mineo Yamakawa
  • Publication number: 20120107944
    Abstract: A sensor for the detection of an analyte comprising a cis-diol moiety, which comprises a holographic element comprising a medium and a hologram disposed throughout the volume of the medium, wherein an optical characteristic of the element changes as a result of a variation of a physical property occurring throughout the volume of the medium, and wherein the medium is a polymer comprising a group of formula (i) wherein n is 0, 1, 2, 3 or 4; each X (if present) is independently is an atom or group which, via an electronic effect, promotes formation of a tetrahedral geometry about the boron atom; and Y is a spacer which, when n is 0 or otherwise optionally, is an atom or group which, via an electronic effect, promotes formation of a tetrahedral geometry about the boron atom. Such a sensor may be used for the detection of glucose.
    Type: Application
    Filed: October 28, 2011
    Publication date: May 3, 2012
    Inventors: Christopher Robin Lowe, Jeffrey Blyth, Satyamoorthy Kabilan, Abid Hussain, Xiaoping Yang, Felicity Kate Sartain, Mei-Ching Lee
  • Patent number: 8148162
    Abstract: A biosensor system determines analyte concentration from an output signal generated by an oxidation/reduction reaction of the analyte. The biosensor system adjusts a correlation for determining analyte concentrations from output signals at one temperature to determining analyte concentrations from output signals at other temperatures. The temperature-adjusted correlation between analyte concentrations and output signals at a reference temperature may be used to determine analyte concentrations from output signals at a sample temperature.
    Type: Grant
    Filed: July 20, 2010
    Date of Patent: April 3, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Huan-Ping Wu, Christine D. Nelson
  • Publication number: 20120077277
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Application
    Filed: December 6, 2011
    Publication date: March 29, 2012
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 8143068
    Abstract: Compounds having enhanced oxidation stability are disclosed. The compounds have an aryl boronic acid residue having one or more electron withdrawing groups on the aromatic moiety which contains the boronic acid residue, such that the molecule has enhanced oxidation resistance as compared to a corresponding molecule without the one or more electron withdrawing groups.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: March 27, 2012
    Assignee: Sensors for Medicine and Science, Inc.
    Inventors: Arthur E. Colvin, Jr., Mark Alan Mortellaro, Aneta Modzelewska
  • Patent number: 8142722
    Abstract: An apparatus for analyzing an aqueous solution, as may be implemented with a hand-held portable electronic device (10) and test element (16). A test pad (32) of the test element responsive in color to a characteristic of an aqueous solution is interrogated by the device by measuring intensity values of an interrogating test light as reflected off of the test pad. The test pad may be supported on an opaque and non-reflective substrate (28) that cooperates with an opaque edge portion (14E) of a test element placement member (14B) and associated side walls (14W) of the device to minimize the impingement of ambient light onto the test pad during interrogation.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: March 27, 2012
    Assignee: Hach Company
    Inventors: David Alexander Nathaniel Morris, Teresa Lynn Swanson
  • Patent number: 8137980
    Abstract: The invention concerns a reagent system for the so-called on-board control of analytical elements, in particular test strips, containing an organic N-oxide or a nitroso compound. The invention also concerns analytical elements containing a reagent system for a detection reaction and a reagent system for an on-board control. Furthermore, the invention concerns a method for checking analytical elements in which a reagent system for an on-board control is examined optically or electrochemically with the aid of a measuring instrument for changes which could indicate a stress of the analytical element.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: March 20, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Volker Unkrig, Christine Nortmeyer, Carina Horn, Michael Marquant, Mihail Onoriu Lungu, Joachim Hoenes, Holger Kotzan, Joerg Dreibholz
  • Patent number: 8133741
    Abstract: Total analysis systems and methods for simultaneously monitoring a suite of biological and/or chemical species in water and/or other process systems are disclosed. The system provides a sample-volume controlled sensor array comprising a fluid delivery device and a plurality of optical sensor elements for determining the presence and total concentrations of multiple analytes in the process system simultaneously. Delivery means are provided to deliver a metered quantity of sample fluid to the sensor array. Image identification algorithms are provided for identifying the analytes based on image intensity, color pattern, positional arrangement, and the like. The methods incorporate multivariate optimization algorithms to analyze multiple sensor responses. This produces analytical results that are typically difficult to obtain without full system or variable compensation.
    Type: Grant
    Filed: August 22, 2006
    Date of Patent: March 13, 2012
    Assignee: General Electric Company
    Inventors: Radislav A. Potyrailo, Prashant V. Shrikhande, Scott M. Boyette, Caibin Xiao, Andrew M. Leach
  • Patent number: 8131474
    Abstract: The invention relates to a method for investigating the glucose metabolism of a human being for disease-relevant and/or disease-related particularities. The glucose concentration g(t1) to g(tn) of a body fluid is measured at time points t1 to tn that are distributed over a period of at least six hours. The data points are then determined in phase space coordinates from the glucose concentration measuring values g(t1) to g(tn). The data points are then processed to highlight disease-relevant and/or disease-related particularities of the glucose metabolism of the investigated human being. The processing of the data points can be implemented by plotting them in a phase space representation or by determining from the data points a disturbance parameter that is correlated to the severity of a disturbance of glucose metabolism.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: March 6, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Arnulf Staib, Johannes Pill, Reinhard Kotulla, Reiner Hegger
  • Publication number: 20120045843
    Abstract: A test element for determining a body fluid, in particular for determining the blood glucose level, comprises a detection region which is charged with a reagent sensitive to the body fluid. A function element is arranged in and/or adjacent to the detection region for detecting at least one status parameter for the detection region, wherein said functional element can be evaluated by means of a status measurement. A method for measuring the test element is also disclosed.
    Type: Application
    Filed: September 2, 2011
    Publication date: February 23, 2012
    Inventors: Hans-Peter Haar, Carina Horn
  • Publication number: 20120045842
    Abstract: An analysis system for detecting at least one analyte in a sample is proposed, in particular for detecting glucose in a bodily fluid. The analysis system is designed to detect the analyte using at least one test element. The test element has at least one analysis zone for detecting the analyte. The test element furthermore comprises at least one coding with at least one test element specific item of information and/or at least one position specific item of information. The analysis system comprises a detector and furthermore at least one transfer device which is designed to afford the detector the possibility of acquiring the analysis zone in at least a first position and to afford the detector the possibility of acquiring the coding in at least a second position which differs from the first position.
    Type: Application
    Filed: February 4, 2011
    Publication date: February 23, 2012
    Inventors: Wolfgang Petrich, Stefan Kalveram, Markus Serr
  • Publication number: 20120040369
    Abstract: Embodiments disclosed herein relate to a sensor comprising an on-board control system and a testing system. The on-board system can determine viability of the control system or the testing system. Also disclosed are methods of using such a sensor.
    Type: Application
    Filed: April 16, 2010
    Publication date: February 16, 2012
    Applicant: Universal Biosensors Pty Ltd
    Inventors: Peter Michael Newman, Alastair M. Hodges
  • Publication number: 20120040468
    Abstract: The application provides a laboratory. The laboratory (400) comprises a portable casing (404). The portable casing (404) comprises a tray unit (407), an actuator unit (405, 412), an analyzer unit (419), and a communication unit (402, 415, 438). The tray unit (407) is used for receiving a cartridge (409). The cartridge (409) comprises an analyte reservoir (430) for receiving an analyte fluid, one or more chemical reagent reservoirs (432) for storing one or more chemical reagent fluids, and one or more channels (434) connecting the chemical reagent reservoirs (432) with the analyte reservoir (430). The channel (434) comprises a measurement area (436) whilst the measure measurement area (436) comprises a sensor. The actuator unit (405, 412) is used for reducing the volume of the analyte reservoir (430) and for reducing the volume of the chemical reagent reservoirs (432). The analyzer unit (419) is used for measuring a physical value in the measurement area (436) using the sensor.
    Type: Application
    Filed: April 27, 2010
    Publication date: February 16, 2012
    Applicant: E-VITAE PTE. LTD.
    Inventor: Mehdi Khaled
  • Patent number: 8101415
    Abstract: A method of adjusting a final signal value measured on a lateral flow assay test strip, by: identifying a pre-determined calibration method for the test strip, wherein the pre-determined calibration method corresponds to the manufacturing lot from which the test strip has been made; measuring signal values while performing a lateral flow assay reaction on a test strip; determining a final signal value; and adjusting the final signal value based upon the identified pre-selected calibration method for the test strip.
    Type: Grant
    Filed: July 5, 2005
    Date of Patent: January 24, 2012
    Assignee: Bayer HealthCare LLC
    Inventor: Benjamin R. Irvin
  • Publication number: 20120009126
    Abstract: The present invention concerns an improved optical method and optical sensing device for determining the levels of polyhydroxyl-substituted organic molecules in vitro and/or in vivo in aqueous media. The range of detection is between about 400 and 800 nm. In particular, a sensory devise is implemented in a mammal to determine sugar levels. Specifically, a dye is combined with a conjugated nitrogen-containing heterocyclic aromatic boronic acid-substituted bis-onium compound in the presence of a sugar, such as fructose or glucose. The viologens are preferred as the aromatic conjugated nitrogen-containing boronic acid substituted compounds. The method is useful to determine sugar levels in a human being.
    Type: Application
    Filed: June 9, 2011
    Publication date: January 12, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Bakthan SINGARAM, Ritchie A. WESSLING
  • Publication number: 20110312004
    Abstract: A test meter system for testing a characteristic of a fluid, the test meter system including a test meter having a housing with an opening adapted to accept a test strip, an interrogation coil within the housing, a pick-up coil within the housing, and a test strip including at least one magneto-electronic-resonance sensor. When the test strip is within the opening, the interrogation coil may utilize magneto-electronic-resonance technology to interrogate the magneto-electronic-resonance sensor and the pick-up coil may be used to sense a resultant oscillation frequency of the magneto-electronic-resonance sensor, the resultant oscillation frequency associated with the characteristic. The test strip may include a plurality of sensors. The sensors may be coated with a coating sensitive to a characteristic of the fluid, where the interrogation reveals information about the fluid characteristic.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 22, 2011
    Applicant: Bayer HealthCare LLC
    Inventors: Swetha Chinnayelka, Jiangfeng Fei, Yuan Wang, Narasinha Parasnis, Hoi-Cheong Steve Sun, Raeann Gifford, Steven Charlton
  • Publication number: 20110313276
    Abstract: An in-vitro non-invasive method for quantifying the lesions of the liver of the patient with metabolic steatosis addressing a diagnostic target, i.e. fibrosis, steatosis and/or steato-hepatitis (NASH) and measuring at least one marker selected from the group consisting of biomarkers and possibly clinical markers and possibly scores, the biomarkers being selected from the group consisting of glycemia, AST (aspartate aminotransferase), ALT (alanine aminotransferase), AST/ALT, AST.
    Type: Application
    Filed: November 18, 2009
    Publication date: December 22, 2011
    Applicants: CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS, UNIVERSITE D'ANGERS
    Inventors: Paul Cales, Christophe Aube, Vincent Roullier
  • Patent number: 8071384
    Abstract: Control and calibration solutions are described that provide control and calibration data that is recognized by a test meter allowing the meter to segregate the control and calibration data from regular test data. Recognition and segregation of the control and calibration data can occur automatically with no additional input from the meter's user. Methods for use of the solutions are also provided.
    Type: Grant
    Filed: October 7, 2008
    Date of Patent: December 6, 2011
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: David W. Burke, Terry A. Beaty, Lance S. Kuhn, Vladimir Svetnik
  • Patent number: 8066639
    Abstract: A glucose measuring system includes a glucose meter that incorporates wireless communication capabilities. The meter can advantageously be a low cost meter by eliminating expensive components, such as the display. The user nevertheless is able to retrieve and view his or her glucose values by referring to displays within the glucose measuring local area network. Feedback via these displays can advantageously be used by the diabetic to create a higher level of confidence and safety.
    Type: Grant
    Filed: June 4, 2004
    Date of Patent: November 29, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Charles L. Nelson, Mark K. Sloan, Robert Y. Jin, Feng Jiang, Jen-Chyun Chen, Arthur Eugene Anderson, III, Charles T. Liamos, Douglas C. Limbach
  • Patent number: 8062902
    Abstract: A mammalian disease detecting system used to provide a visual indication of a possible disease state includes particles made of a material that is substantially clear or transparent to permit the easy visual detection of blood in urine of a mammal. The system also includes additives to permit visually detection of possible disease states or infections in mammals, such additives being of the type that are not reactive with the particular material.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: November 22, 2011
    Inventor: Francois Mestrallet
  • Publication number: 20110275985
    Abstract: Disclosed are magnetic nanosensors or transducers that permit measurement of a physical parameter in an analyte via magnetic reasonance measurements, in particular of non-agglomerative assays. More particularly, in certain embodiments, the invention relates to designs of nanoparticle reagents and responsive polymer coated magnetic nanoparticles. Additionally provided are methods of use of nanoparticle reagents and responsive polymer coated magnetic nanoparticles for the detection of a stimulus or an analyte with NMR detectors.
    Type: Application
    Filed: July 2, 2009
    Publication date: November 10, 2011
    Applicant: T2 Biosystems, Inc.
    Inventors: Thomas Jay Lowery, JR., James J. Koziarz, Douglas A. Levinson, David A. Berry, Tuan A. Elstrom, Sonia Kumar, Mark John Audeh
  • Patent number: 8048680
    Abstract: A sensor for the detection of an analyte comprising a cis-diol moiety, which comprises a holographic element comprising a medium and a hologram disposed throughout the volume of the medium, wherein an optical characteristic of the element changes as a result of a variation of a physical property occurring throughout the volume of the medium, and wherein the medium is a polymer comprising a group of formula (I): wherein n is 0, 1, 2, 3 or 4; each X (if present) is independently is an atom or group which, via an electronic effect, promotes formation of a tetrahedral geometry about the boron atom; and Y is a spacer which, when n is 0 or otherwise optionally, is an atom or group which, via an electronic effect, promotes formation of a tetrahedral geometry about the boron atom. Such a sensor may be used for the detection of glucose.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: November 1, 2011
    Assignees: Smart Holograms Limited, Cambridge Enterprise Ltd.
    Inventors: Christopher Robin Lowe, Jeffrey Blyth, Satyamoorthy Kabilan, Abid Hussain, Xiaoping Yang, Felicity Kate Sartain, Mei-Ching Lee
  • Publication number: 20110245317
    Abstract: This application is directed to methods for improving glucose control by administering metformin in combination with a DPP-IV inhibitor to a patient in need thereof, in an amount sufficient to control the glucose level over an extended period of time.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 6, 2011
    Inventor: Thomas Edward HUGHES
  • Publication number: 20110212532
    Abstract: An analytical system comprising a replaceable magazine (12) for providing a plurality of test units that react to an analyte and a measuring device (14) for processing the test units, wherein the magazine (12) is provided with a code (26) that can be registered by the measuring device (14). In order to enable the simplest possible coding, it is proposed that the code (26) comprises an unique magazine identifier (28) for the magazine (12) and that the measuring device (14) has a magazine-independent test counter (16) which registers the processing of a test unit and a counter memory (18) to store the magazine identifier (28) and a corresponding count of the test counter (16).
    Type: Application
    Filed: May 10, 2011
    Publication date: September 1, 2011
    Inventor: Herbert Harttig
  • Patent number: 8008088
    Abstract: Small Molecule Metabolite Reporters (SMMRs) for use as in vivo glucose biosensors, sensor compositions, and methods of use, are described. The SMMRs include boronic acid-containing xanthene, coumarin, carbostyril and phenalene-based small molecules which are used for monitoring glucose in vivo, advantageously on the skin.
    Type: Grant
    Filed: June 26, 2006
    Date of Patent: August 30, 2011
    Assignee: Masimo Laboratories, Inc.
    Inventors: Emile M. Bellott, Dongsheng Bu, James J. Childs, Christopher Lambert, Hubert A. Nienaber, Shirley J. Shi, Zhaolin Wang, Jerome J. Workman, Alex R. Zelenchuk
  • Patent number: 8003397
    Abstract: A polymeric sensing fluid for detecting the presence of glucose and systems and methods of its use are generally disclosed. The polymeric sensing fluid includes a polymer in a solvent (e.g., an aqueous solvent). The polymer has a plurality of boronic acid moieties extending from its polymeric backbone. As such, the polymeric sensing fluid is configured to increase in viscosity upon addition of glucose due to crosslinking between the boronic acid moieties of the polymer and glucose.
    Type: Grant
    Filed: January 29, 2009
    Date of Patent: August 23, 2011
    Assignee: University of South Carolina
    Inventors: Qian Wang, Siqi Li
  • Patent number: 7998407
    Abstract: A system and method for measuring substance concentrations is provided. The system has a test strip container for receiving a test strip(s). The container has a sealing device, a counter device that counts a number of opening processes of the sealing device, a data carrier that stores batch-specific data of the test strip(s), a data transmission device for wireless transmission of the data and of the number. An analysis module has a device for measuring substance concentrations by the test strip(s), and a data-receiving device for wireless reception of the data from the data transmission device and of the number. The method records the number and stores the number on the data carrier; sends data and the number by wireless transmission to the analysis module, and determines a substance concentration by the test strip(s). Also or instead, the counter device counts a time duration of the opening processes.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: August 16, 2011
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Albert Wohland
  • Patent number: 7981363
    Abstract: A method of measuring an analyte in a biological fluid comprises applying an excitation signal having a DC component and an AC component. The AC and DC responses are measured; a corrected DC response is determined using the AC response; and a concentration of the analyte is determined based upon the corrected DC response. Other methods and devices are disclosed.
    Type: Grant
    Filed: January 8, 2008
    Date of Patent: July 19, 2011
    Assignees: Roche Diagnostics Operations, Inc., Roche Operations Ltd.
    Inventors: David W. Burke, Lance S. Kuhn, Terry A. Beaty, Vladimir Svetnik
  • Publication number: 20110171742
    Abstract: Novel pyridinium salts functionalized with boronic acid and methods of making them are disclosed. When combined with a fluorescent dye, the compounds are useful in the detection of polyhydroxyl-substituted organic molecules.
    Type: Application
    Filed: March 22, 2011
    Publication date: July 14, 2011
    Applicant: GLUMETRICS, INC.
    Inventors: SOYA GAMSEY, RITCHIE A. WESSLING
  • Patent number: 7977112
    Abstract: A method of measuring an analyte in a biological fluid comprises applying an excitation signal having a DC component and an AC component. The AC and DC responses are measured; a corrected DC response is determined using the AC response; and a concentration of the analyte is determined based upon the corrected DC response. Other methods and devices are disclosed.
    Type: Grant
    Filed: December 9, 2008
    Date of Patent: July 12, 2011
    Assignees: Roche Diagnostics Operations, Inc., Roche Operations Ltd.
    Inventors: David W. Burke, Lance S. Kuhn, James Maxwell
  • Patent number: 7972861
    Abstract: Methods and devices for performing in situ hematocrit adjustments during glucose testing using glucose-monitoring products and using those adjusted values to estimate the hematocrit value of blood samples to reduce or eliminate the assay bias caused by the different hematocrit levels of blood samples. One method involves measuring the glucose value, Glum, of the blood sample; measuring the resistance of the blood sample (Rcell) using a biosensor reagent; measuring the resistance of plasma (Rplasma) using the biosensor reagent; determining the calculated resistance of red blood cells, RRBC, of the blood sample according to the relationship RRBC=Rcell?Rplasma; calculating the percent hematocrit, % Hctc, of the blood sample; determining whether to adjust the glucose value, Glum, to an adjusted glucose value, Gluadj; and using the percent hematocrit, % Hctc, and either the glucose value, Glum, or the adjusted glucose value, Gluadj, to adjust for any bias of the biosensor reagent.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: July 5, 2011
    Assignee: Bayer Healthcare LLC
    Inventors: Yingping Deng, Sherry J. Jamison
  • Patent number: 7972862
    Abstract: A method of sensing glucose in subjects includes the steps of providing a sensing solution including a plurality of metal ions, introducing a bodily fluid sample from a subject into the sensing solution. An optically-based measurable derived from directing incident light on the solution is generated. The concentration of glucose in the bodily fluid using the measurable is then determined which permits the blood glucose level to be derived.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: July 5, 2011
    Assignee: The University of Central Florida Research Foundation, Inc.
    Inventor: Florencio E. Hernández
  • Publication number: 20110151571
    Abstract: One embodiment includes a memory unit for use in connection with a plurality of fluid sample test elements, wherein the memory unit comprises a plurality of memory portions. In one aspect of the embodiment, the memory unit comprises at least one memory portion configured to communicate calibration and expiration information relating to a lot of test elements, to a meter operably connectable with such test elements, and at least one other memory portion configured for storage and communication of data, such as measurement results, relating to the use of the test elements in analyzing a fluid sample. Further embodiments include apparatuses, systems, methods, kits and combinations of test elements and memory units.
    Type: Application
    Filed: December 23, 2009
    Publication date: June 23, 2011
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Scott Wooldridge
  • Publication number: 20110136241
    Abstract: Molecular bioprofiles comprising biologically correlated and relevant analytes that impact the biological state of a human health condition compared to a control population are provided. These molecular bioprofiles are useful in several ways including but not limited to, monitoring a disease or condition's progression, evaluating the impact of an agent or compound on a disease or condition, evaluating the impact of a lifestyle change on a disease or condition and assessing the risk of the disease or condition to a subject. Type II diabetes molecular bioprofiles are of particular interest.
    Type: Application
    Filed: December 8, 2009
    Publication date: June 9, 2011
    Inventor: Stephen Naylor